Arrowstreet Capital’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,375,342
Closed -$65.3M 1531
2022
Q3
$65.3M Buy
2,375,342
+532,067
+29% +$13.2M 0.1% 192
2022
Q2
$42.5M Buy
1,843,275
+1,006,288
+120% +$23.5M 0.06% 243
2022
Q1
$18.2M Sell
836,987
-739,763
-47% -$15.4M 0.02% 417
2021
Q4
$33.7M Buy
1,576,750
+204,634
+15% +$4.29M 0.04% 359
2021
Q3
$28.7M Sell
1,372,116
-1,552,725
-53% -$33.9M 0.04% 434
2021
Q2
$67.4M Buy
2,924,841
+690,008
+31% +$15.9M 0.08% 260
2021
Q1
$49.4M Sell
2,234,833
-2,285,267
-51% -$52.9M 0.07% 292
2020
Q4
$84.3M Buy
4,520,100
+303,595
+7% +$4.99M 0.12% 153
2020
Q3
$61.2M Buy
4,216,505
+414,567
+11% +$5.27M 0.1% 194
2020
Q2
$42.6M Buy
3,801,938
+3,363,573
+767% +$37.8M 0.08% 239
2020
Q1
$4.38M Sell
438,365
-2,579
-0.6% -$36.1K 0.01% 790
2019
Q4
$7.23M Buy
440,944
+245,012
+125% +$3.29M 0.02% 737
2019
Q3
$2.37M Buy
+195,932
New +$2.69M 0.01% 928

Other funds holding CHNG

Arrowstreet Capital's CHNG Position: Q4 2022 in Review

Arrowstreet Capital sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 2,375,342 shares — an estimated $65.3M sold.

Arrowstreet Capital first reported a position in CHNG in Q3 2019 and held it in 13 quarters. The position peaked at $84.3M in Q4 2020. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Arrowstreet Capital reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Arrowstreet Capital sold 2,375,342 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $65.3M.
  • Arrowstreet Capital first reported a position in Change Healthcare Inc. Common Stock in Q3 2019 and held it in 13 quarters.
  • Arrowstreet Capital's Change Healthcare Inc. Common Stock position peaked at $84.3M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.